25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

EZZ (EZZ Life Science Holdings Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze EZZ Life Science Holdings Ltd together

I guess you are interested in EZZ Life Science Holdings Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – EZZ Life Science Holdings Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – EZZ Life Science Holdings Ltd’s Price Targets

I'm going to help you getting a better view of EZZ Life Science Holdings Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about EZZ Life Science Holdings Ltd

I send you an email if I find something interesting about EZZ Life Science Holdings Ltd.

1. Quick Overview

1.1. Quick analysis of EZZ Life Science Holdings Ltd (30 sec.)










1.2. What can you expect buying and holding a share of EZZ Life Science Holdings Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.10
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
A$0.60
Expected worth in 1 year
A$1.17
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
A$0.73
Return On Investment
26.3%

For what price can you sell your share?

Current Price per Share
A$2.77
Expected price per share
A$2.27 - A$3.2390557823129
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of EZZ Life Science Holdings Ltd (5 min.)




Live pricePrice per Share (EOD)
A$2.77
Intrinsic Value Per Share
A$0.63 - A$2.13
Total Value Per Share
A$1.22 - A$2.72

2.2. Growth of EZZ Life Science Holdings Ltd (5 min.)




Is EZZ Life Science Holdings Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$18.2m$13.8m$4.4m24.1%

How much money is EZZ Life Science Holdings Ltd making?

Current yearPrevious yearGrowGrow %
Making money$4.3m$4.5m-$152.4k-3.5%
Net Profit Margin10.1%10.5%--

How much money comes from the company's main activities?

2.3. Financial Health of EZZ Life Science Holdings Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#489 / 844

Most Revenue
#160 / 844

Most Profit
#106 / 844

Most Efficient
#114 / 844
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of EZZ Life Science Holdings Ltd?

Welcome investor! EZZ Life Science Holdings Ltd's management wants to use your money to grow the business. In return you get a share of EZZ Life Science Holdings Ltd.

First you should know what it really means to hold a share of EZZ Life Science Holdings Ltd. And how you can make/lose money.

Speculation

The Price per Share of EZZ Life Science Holdings Ltd is A$2.77. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of EZZ Life Science Holdings Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in EZZ Life Science Holdings Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.60. Based on the TTM, the Book Value Change Per Share is A$0.14 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of EZZ Life Science Holdings Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.093.4%0.093.4%0.103.5%0.082.9%0.062.1%0.051.6%
Usd Book Value Change Per Share0.093.4%0.093.4%0.093.4%0.082.8%0.062.0%0.062.0%
Usd Dividend Per Share0.030.9%0.030.9%0.010.5%0.020.6%0.010.4%0.010.3%
Usd Total Gains Per Share0.124.3%0.124.3%0.113.9%0.093.4%0.072.4%0.062.3%
Usd Price Per Share2.00-2.00-0.42-0.89-0.60-0.43-
Price to Earnings Ratio21.52-21.52-4.40-10.26-9.83-7.02-
Price-to-Total Gains Ratio16.88-16.88-3.92-8.49-10.51-10.51-
Price to Book Ratio5.16-5.16-1.44-2.60-1.98-1.42-
Price-to-Total Gains Ratio16.88-16.88-3.92-8.49-10.51-10.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.804378
Number of shares554
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.01
Usd Book Value Change Per Share0.090.06
Usd Total Gains Per Share0.120.07
Gains per Quarter (554 shares)65.6336.74
Gains per Year (554 shares)262.53146.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15620725323124137
211141451646248284
316762177969371431
4222828104293495578
527810351305116619725
633412421568139743872
7389144918311628671019
8445165520941859911166
95001862235720811141313
105562069262023112381460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of EZZ Life Science Holdings Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1430.1430%0.143+0%0.118+21%0.086+67%0.085+69%
Book Value Per Share--0.5950.5950%0.452+32%0.452+32%0.362+64%0.285+109%
Current Ratio--5.7705.7700%5.962-3%5.842-1%5.714+1%4.702+23%
Debt To Asset Ratio--0.1730.1730%0.166+4%0.171+1%0.175-1%0.274-37%
Debt To Equity Ratio--0.2090.2090%0.198+5%0.206+2%0.212-1%0.583-64%
Dividend Per Share--0.0390.0390%0.023+68%0.025+56%0.016+140%0.012+208%
Enterprise Value--159799941.000159799941.0000%45456046.000+252%77906069.667+105%66340861.000+141%66340861.000+141%
Eps--0.1430.1430%0.148-3%0.122+17%0.088+63%0.070+104%
Ev To Ebitda Ratio--14.39314.3930%4.381+229%8.121+77%10.249+40%10.249+40%
Ev To Sales Ratio--2.3902.3900%0.684+249%1.280+87%1.487+61%1.487+61%
Free Cash Flow Per Share--0.0870.0870%0.122-29%0.097-11%0.059+47%0.052+66%
Free Cash Flow To Equity Per Share--0.0410.0410%0.109-63%0.072-44%0.066-38%0.057-28%
Gross Profit Margin---3.795-3.7950%-4.346+15%-4.268+12%-3.386-11%-2.614-31%
Intrinsic Value_10Y_max--2.129----------
Intrinsic Value_10Y_min--0.625----------
Intrinsic Value_1Y_max--0.122----------
Intrinsic Value_1Y_min--0.061----------
Intrinsic Value_3Y_max--0.437----------
Intrinsic Value_3Y_min--0.185----------
Intrinsic Value_5Y_max--0.835----------
Intrinsic Value_5Y_min--0.312----------
Market Cap130669764.000-11%144821724.000144821724.0000%30662580.000+372%64391418.000+125%43446517.200+233%31033226.571+367%
Net Profit Margin--0.1010.1010%0.105-4%0.1010%0.096+4%0.092+9%
Operating Margin--0.1580.1580%0.150+5%0.147+8%0.137+16%0.130+21%
Operating Ratio--0.8520.8520%0.8540%0.860-1%0.871-2%0.881-3%
Pb Ratio4.653-11%5.1565.1560%1.438+259%2.603+98%1.984+160%1.417+264%
Pe Ratio19.415-11%21.51721.5170%4.403+389%10.265+110%9.825+119%7.018+207%
Price Per Share2.770-11%3.0703.0700%0.650+372%1.365+125%0.921+233%0.658+367%
Price To Free Cash Flow Ratio31.930-11%35.38835.3880%5.347+562%15.085+135%-356.133+1106%-254.381+819%
Price To Total Gains Ratio15.230-11%16.88016.8800%3.920+331%8.487+99%10.505+61%10.505+61%
Quick Ratio--4.5934.5930%5.326-14%5.035-9%5.071-9%4.229+9%
Return On Assets--0.1980.1980%0.273-27%0.226-12%0.187+6%0.194+2%
Return On Equity--0.2400.2400%0.327-27%0.272-12%0.226+6%0.333-28%
Total Gains Per Share--0.1820.1820%0.166+10%0.143+27%0.102+79%0.098+86%
Usd Book Value--18294774.19118294774.1910%13889696.673+32%13894426.054+32%11137053.546+64%8762486.793+109%
Usd Book Value Change Per Share--0.0930.0930%0.093+0%0.077+21%0.056+67%0.055+69%
Usd Book Value Per Share--0.3880.3880%0.294+32%0.295+32%0.236+64%0.186+109%
Usd Dividend Per Share--0.0250.0250%0.015+68%0.016+56%0.010+140%0.008+208%
Usd Enterprise Value--104093681.567104093681.5670%29610068.364+252%50748013.781+105%43214436.855+141%43214436.855+141%
Usd Eps--0.0930.0930%0.096-3%0.080+17%0.057+63%0.046+104%
Usd Free Cash Flow--2665814.7652665814.7650%3735493.687-29%2983298.005-11%1819192.790+47%1606230.309+66%
Usd Free Cash Flow Per Share--0.0570.0570%0.079-29%0.063-11%0.039+47%0.034+66%
Usd Free Cash Flow To Equity Per Share--0.0270.0270%0.071-63%0.047-44%0.043-38%0.037-28%
Usd Market Cap85118284.270-11%94336871.01494336871.0140%19973604.612+372%41944569.685+125%28301061.304+233%20215043.789+367%
Usd Price Per Share1.804-11%2.0002.0000%0.423+372%0.889+125%0.600+233%0.429+367%
Usd Profit--4384209.2674384209.2670%4536667.483-3%3761760.306+17%2692585.350+63%2147537.474+104%
Usd Revenue--43561522.31743561522.3170%43281211.869+1%37012633.116+18%27068209.939+61%21986809.727+98%
Usd Total Gains Per Share--0.1180.1180%0.108+10%0.093+27%0.066+79%0.064+86%
 EOD+4 -4MRQTTM+0 -0YOY+21 -193Y+24 -165Y+32 -810Y+32 -8

3.3 Fundamental Score

Let's check the fundamental score of EZZ Life Science Holdings Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.415
Price to Book Ratio (EOD)Between0-14.653
Net Profit Margin (MRQ)Greater than00.101
Operating Margin (MRQ)Greater than00.158
Quick Ratio (MRQ)Greater than14.593
Current Ratio (MRQ)Greater than15.770
Debt to Asset Ratio (MRQ)Less than10.173
Debt to Equity Ratio (MRQ)Less than10.209
Return on Equity (MRQ)Greater than0.150.240
Return on Assets (MRQ)Greater than0.050.198
Total8/10 (80.0%)

3.4 Technical Score

Let's check the technical score of EZZ Life Science Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.600
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About EZZ Life Science Holdings Ltd

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.

Fundamental data was last updated by Penke on 2025-10-05 11:29:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit EZZ Life Science Holdings Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare EZZ Life Science Holdings Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 10.1% means that $0.10 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of EZZ Life Science Holdings Ltd:

  • The MRQ is 10.1%. The company is making a huge profit. +2
  • The TTM is 10.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.1%TTM10.1%0.0%
TTM10.1%YOY10.5%-0.4%
TTM10.1%5Y9.6%+0.4%
5Y9.6%10Y9.2%+0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.1%-68.9%+79.0%
TTM10.1%-157.5%+167.6%
YOY10.5%-189.1%+199.6%
3Y10.1%-262.3%+272.4%
5Y9.6%-336.5%+346.1%
10Y9.2%-471.4%+480.6%
4.3.1.2. Return on Assets

Shows how efficient EZZ Life Science Holdings Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare EZZ Life Science Holdings Ltd to the Biotechnology industry mean.
  • 19.8% Return on Assets means that EZZ Life Science Holdings Ltd generated $0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of EZZ Life Science Holdings Ltd:

  • The MRQ is 19.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 19.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ19.8%TTM19.8%0.0%
TTM19.8%YOY27.3%-7.4%
TTM19.8%5Y18.7%+1.1%
5Y18.7%10Y19.4%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.8%-11.9%+31.7%
TTM19.8%-11.8%+31.6%
YOY27.3%-11.1%+38.4%
3Y22.6%-12.0%+34.6%
5Y18.7%-11.8%+30.5%
10Y19.4%-13.9%+33.3%
4.3.1.3. Return on Equity

Shows how efficient EZZ Life Science Holdings Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare EZZ Life Science Holdings Ltd to the Biotechnology industry mean.
  • 24.0% Return on Equity means EZZ Life Science Holdings Ltd generated $0.24 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of EZZ Life Science Holdings Ltd:

  • The MRQ is 24.0%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 24.0%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ24.0%TTM24.0%0.0%
TTM24.0%YOY32.7%-8.7%
TTM24.0%5Y22.6%+1.3%
5Y22.6%10Y33.3%-10.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ24.0%-14.1%+38.1%
TTM24.0%-14.7%+38.7%
YOY32.7%-15.3%+48.0%
3Y27.2%-16.7%+43.9%
5Y22.6%-17.1%+39.7%
10Y33.3%-19.7%+53.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of EZZ Life Science Holdings Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient EZZ Life Science Holdings Ltd is operating .

  • Measures how much profit EZZ Life Science Holdings Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare EZZ Life Science Holdings Ltd to the Biotechnology industry mean.
  • An Operating Margin of 15.8% means the company generated $0.16  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of EZZ Life Science Holdings Ltd:

  • The MRQ is 15.8%. The company is operating efficient. +1
  • The TTM is 15.8%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ15.8%TTM15.8%0.0%
TTM15.8%YOY15.0%+0.8%
TTM15.8%5Y13.7%+2.2%
5Y13.7%10Y13.0%+0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.8%-153.1%+168.9%
TTM15.8%-265.6%+281.4%
YOY15.0%-242.6%+257.6%
3Y14.7%-247.2%+261.9%
5Y13.7%-326.3%+340.0%
10Y13.0%-487.4%+500.4%
4.3.2.2. Operating Ratio

Measures how efficient EZZ Life Science Holdings Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.85 means that the operating costs are $0.85 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of EZZ Life Science Holdings Ltd:

  • The MRQ is 0.852. The company is less efficient in keeping operating costs low.
  • The TTM is 0.852. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.852TTM0.8520.000
TTM0.852YOY0.854-0.002
TTM0.8525Y0.871-0.020
5Y0.87110Y0.881-0.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8521.861-1.009
TTM0.8522.729-1.877
YOY0.8542.820-1.966
3Y0.8603.542-2.682
5Y0.8714.614-3.743
10Y0.8816.171-5.290
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of EZZ Life Science Holdings Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if EZZ Life Science Holdings Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.77 means the company has $5.77 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of EZZ Life Science Holdings Ltd:

  • The MRQ is 5.770. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.770. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.770TTM5.7700.000
TTM5.770YOY5.962-0.192
TTM5.7705Y5.714+0.056
5Y5.71410Y4.702+1.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7703.414+2.356
TTM5.7703.605+2.165
YOY5.9624.048+1.914
3Y5.8424.419+1.423
5Y5.7145.731-0.017
10Y4.7026.121-1.419
4.4.3.2. Quick Ratio

Measures if EZZ Life Science Holdings Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare EZZ Life Science Holdings Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 4.59 means the company can pay off $4.59 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of EZZ Life Science Holdings Ltd:

  • The MRQ is 4.593. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.593. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.593TTM4.5930.000
TTM4.593YOY5.326-0.733
TTM4.5935Y5.071-0.478
5Y5.07110Y4.229+0.842
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5932.783+1.810
TTM4.5933.128+1.465
YOY5.3263.787+1.539
3Y5.0354.322+0.713
5Y5.0715.680-0.609
10Y4.2296.495-2.266
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of EZZ Life Science Holdings Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of EZZ Life Science Holdings Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare EZZ Life Science Holdings Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.17 means that EZZ Life Science Holdings Ltd assets are financed with 17.3% credit (debt) and the remaining percentage (100% - 17.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of EZZ Life Science Holdings Ltd:

  • The MRQ is 0.173. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.173. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.173TTM0.1730.000
TTM0.173YOY0.166+0.007
TTM0.1735Y0.175-0.002
5Y0.17510Y0.274-0.099
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1730.346-0.173
TTM0.1730.364-0.191
YOY0.1660.337-0.171
3Y0.1710.350-0.179
5Y0.1750.349-0.174
10Y0.2740.380-0.106
4.5.4.2. Debt to Equity Ratio

Measures if EZZ Life Science Holdings Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare EZZ Life Science Holdings Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 20.9% means that company has $0.21 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of EZZ Life Science Holdings Ltd:

  • The MRQ is 0.209. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.209. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.209TTM0.2090.000
TTM0.209YOY0.198+0.011
TTM0.2095Y0.212-0.003
5Y0.21210Y0.583-0.371
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2090.402-0.193
TTM0.2090.448-0.239
YOY0.1980.436-0.238
3Y0.2060.471-0.265
5Y0.2120.469-0.257
10Y0.5830.517+0.066
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings EZZ Life Science Holdings Ltd generates.

  • Above 15 is considered overpriced but always compare EZZ Life Science Holdings Ltd to the Biotechnology industry mean.
  • A PE ratio of 21.52 means the investor is paying $21.52 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of EZZ Life Science Holdings Ltd:

  • The EOD is 19.415. Based on the earnings, the company is fair priced.
  • The MRQ is 21.517. Based on the earnings, the company is fair priced.
  • The TTM is 21.517. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD19.415MRQ21.517-2.103
MRQ21.517TTM21.5170.000
TTM21.517YOY4.403+17.115
TTM21.5175Y9.825+11.692
5Y9.82510Y7.018+2.807
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD19.415-2.866+22.281
MRQ21.517-2.330+23.847
TTM21.517-2.657+24.174
YOY4.403-3.622+8.025
3Y10.265-3.737+14.002
5Y9.825-5.857+15.682
10Y7.018-6.966+13.984
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of EZZ Life Science Holdings Ltd:

  • The EOD is 31.930. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 35.388. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 35.388. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD31.930MRQ35.388-3.458
MRQ35.388TTM35.3880.000
TTM35.388YOY5.347+30.041
TTM35.3885Y-356.133+391.521
5Y-356.13310Y-254.381-101.752
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD31.930-3.523+35.453
MRQ35.388-2.911+38.299
TTM35.388-3.682+39.070
YOY5.347-4.209+9.556
3Y15.085-5.187+20.272
5Y-356.133-8.367-347.766
10Y-254.381-9.883-244.498
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of EZZ Life Science Holdings Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.16 means the investor is paying $5.16 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of EZZ Life Science Holdings Ltd:

  • The EOD is 4.653. Based on the equity, the company is fair priced.
  • The MRQ is 5.156. Based on the equity, the company is overpriced. -1
  • The TTM is 5.156. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.653MRQ5.156-0.504
MRQ5.156TTM5.1560.000
TTM5.156YOY1.438+3.718
TTM5.1565Y1.984+3.172
5Y1.98410Y1.417+0.567
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.6532.499+2.154
MRQ5.1562.059+3.097
TTM5.1562.224+2.932
YOY1.4382.464-1.026
3Y2.6032.646-0.043
5Y1.9843.755-1.771
10Y1.4174.482-3.065
4.6.2. Total Gains per Share

2.4. Latest News of EZZ Life Science Holdings Ltd

Does EZZ Life Science Holdings Ltd still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from EZZ Life Science Holdings Ltd to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-10-09
22:02
3 Promising ASX Penny Stocks With Market Caps Under A$500MRead
2025-10-08
22:03
ASX Penny Stocks: 3 Picks With Market Caps Under A$3BRead
2025-10-05
22:02
ASX Penny Stocks Spotlight Dimerix And Two More Hidden GemsRead
2025-10-03
05:04
EZZ Life Science Holdings And 2 Other Promising ASX Penny StocksRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of EZZ Life Science Holdings Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets33,957
Total Liabilities5,871
Total Stockholder Equity28,085
 As reported
Total Liabilities 5,871
Total Stockholder Equity+ 28,085
Total Assets = 33,957

Assets

Total Assets33,957
Total Current Assets33,038
Long-term Assets918
Total Current Assets
Cash And Cash Equivalents 20,849
Short-term Investments 891
Net Receivables 4,558
Inventory 2,433
Other Current Assets 5,198
Total Current Assets  (as reported)33,038
Total Current Assets  (calculated)33,930
+/- 891
Long-term Assets
Property Plant Equipment 890
Intangible Assets 28
Long-term Assets  (as reported)918
Long-term Assets  (calculated)918
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,726
Long-term Liabilities145
Total Stockholder Equity28,085
Total Current Liabilities
Short-term Debt 609
Accounts payable 3,456
Other Current Liabilities 1,661
Total Current Liabilities  (as reported)5,726
Total Current Liabilities  (calculated)5,726
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)145
Long-term Liabilities  (calculated)0
+/- 145
Total Stockholder Equity
Common Stock8,737
Retained Earnings 19,318
Accumulated Other Comprehensive Income 31
Total Stockholder Equity (as reported)28,085
Total Stockholder Equity (calculated)28,085
+/-0
Other
Capital Stock8,737
Cash and Short Term Investments 20,849
Common Stock Shares Outstanding 46,249
Liabilities and Stockholders Equity 33,957
Net Debt -20,545
Net Invested Capital 28,085
Net Working Capital 27,312
Property Plant and Equipment Gross 1,395
Short Long Term Debt Total 304



5.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
> Total Assets 
0
2,915
11,629
12,039
14,265
17,641
25,552
33,957
33,95725,55217,64114,26512,03911,6292,9150
   > Total Current Assets 
0
2,824
11,316
11,734
13,973
17,006
24,912
33,038
33,03824,91217,00613,97311,73411,3162,8240
       Cash And Cash Equivalents 
0
414
8,407
8,854
10,465
13,831
19,023
20,849
20,84919,02313,83110,4658,8548,4074140
       Short-term Investments 
0
0
0
0
0
0
556
891
891556000000
       Net Receivables 
0
2,410
2,535
2,189
2,294
1,388
2,674
4,558
4,5582,6741,3882,2942,1892,5352,4100
       Other Current Assets 
0
0
341
420
902
941
1,814
5,198
5,1981,81494190242034100
   > Long-term Assets 
0
90
313
305
293
635
640
918
918640635293305313900
       Property Plant Equipment 
0
89
97
132
149
604
622
890
89062260414913297890
       Intangible Assets 
0
1
1
11
19
19
19
28
2819191911110
       Other Assets 
0
1
4
162
125
0
0
0
000125162410
> Total Liabilities 
0
2,091
3,776
1,931
2,878
3,058
4,229
5,871
5,8714,2293,0582,8781,9313,7762,0910
   > Total Current Liabilities 
0
2,091
3,776
1,930
2,817
2,935
4,178
5,726
5,7264,1782,9352,8171,9303,7762,0910
       Short-term Debt 
0
0
64
158
209
355
248
609
6092483552091586400
       Accounts payable 
0
1,240
3,201
605
728
1,318
2,733
3,456
3,4562,7331,3187286053,2011,2400
       Other Current Liabilities 
0
851
-17
987
1,637
969
40
1,661
1,661409691,637987-178510
   > Long-term Liabilities 
0
0
0
1
61
124
51
145
14551124611000
       Long term Debt Total 
0
0
0
0
0
124
0
0
0012400000
       Other Liabilities 
0
0
0
1
61
0
0
0
000611000
> Total Stockholder Equity
0
824
7,853
10,108
11,387
14,582
21,323
28,085
28,08521,32314,58211,38710,1087,8538240
   Common Stock
0
0
5,618
5,667
5,823
5,999
6,853
8,737
8,7376,8535,9995,8235,6675,61800
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
1
16
31
3116100000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
0
0
0
0
0
1
0
0
00100000



5.3. Balance Sheets

Currency in AUD. All numbers in thousands.




5.4. Cash Flows

Currency in AUD. All numbers in thousands.




5.5. Income Statements

Currency in AUD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue66,874
Cost of Revenue-17,154
Gross Profit49,72049,720
 
Operating Income (+$)
Gross Profit49,720
Operating Expense-39,789
Operating Income9,9309,930
 
Operating Expense (+$)
Research Development0
Selling General Administrative3,600
Selling And Marketing Expenses32,272
Operating Expense39,78935,873
 
Net Interest Income (+$)
Interest Income418
Interest Expense-28
Other Finance Cost-0
Net Interest Income390
 
Pretax Income (+$)
Operating Income9,930
Net Interest Income390
Other Non-Operating Income Expenses0
Income Before Tax (EBT)10,5869,275
EBIT - interestExpense = 10,564
10,586
6,758
Interest Expense28
Earnings Before Interest and Taxes (EBIT)10,59210,614
Earnings Before Interest and Taxes (EBITDA)11,102
 
After tax Income (+$)
Income Before Tax10,586
Tax Provision-3,856
Net Income From Continuing Ops6,7306,730
Net Income6,730
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses56,943
Total Other Income/Expenses Net656-390
 

Technical Analysis of EZZ Life Science Holdings Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of EZZ Life Science Holdings Ltd. The general trend of EZZ Life Science Holdings Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine EZZ Life Science Holdings Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. EZZ Life Science Holdings Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of EZZ Life Science Holdings Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.72 < 2.78 < 3.2390557823129.

The bearish price targets are: 2.27 > 2.27 > 2.27.

Know someone who trades $EZZ? Share this with them.👇

EZZ Life Science Holdings Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of EZZ Life Science Holdings Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

EZZ Life Science Holdings Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of EZZ Life Science Holdings Ltd.

EZZ Life Science Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) ChartEZZ Life Science Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of EZZ Life Science Holdings Ltd. The current adx is .

EZZ Life Science Holdings Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of EZZ Life Science Holdings Ltd.

EZZ Life Science Holdings Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of EZZ Life Science Holdings Ltd.

EZZ Life Science Holdings Ltd Daily Relative Strength Index (RSI) ChartEZZ Life Science Holdings Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of EZZ Life Science Holdings Ltd.

EZZ Life Science Holdings Ltd Daily Stochastic Oscillator ChartEZZ Life Science Holdings Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of EZZ Life Science Holdings Ltd.

EZZ Life Science Holdings Ltd Daily Commodity Channel Index (CCI) ChartEZZ Life Science Holdings Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of EZZ Life Science Holdings Ltd.

EZZ Life Science Holdings Ltd Daily Chande Momentum Oscillator (CMO) ChartEZZ Life Science Holdings Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of EZZ Life Science Holdings Ltd.

EZZ Life Science Holdings Ltd Daily Williams %R ChartEZZ Life Science Holdings Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of EZZ Life Science Holdings Ltd.

EZZ Life Science Holdings Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of EZZ Life Science Holdings Ltd.

EZZ Life Science Holdings Ltd Daily Average True Range (ATR) ChartEZZ Life Science Holdings Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of EZZ Life Science Holdings Ltd.

EZZ Life Science Holdings Ltd Daily On-Balance Volume (OBV) ChartEZZ Life Science Holdings Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of EZZ Life Science Holdings Ltd.

EZZ Life Science Holdings Ltd Daily Money Flow Index (MFI) ChartEZZ Life Science Holdings Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for EZZ Life Science Holdings Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-05-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-10-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-09STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

EZZ Life Science Holdings Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of EZZ Life Science Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.600
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of EZZ Life Science Holdings Ltd with someone you think should read this too:
  • Are you bullish or bearish on EZZ Life Science Holdings Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about EZZ Life Science Holdings Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about EZZ Life Science Holdings Ltd

I send you an email if I find something interesting about EZZ Life Science Holdings Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about EZZ Life Science Holdings Ltd.

Receive notifications about EZZ Life Science Holdings Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.